CLINICAL TRIALS

Through its 500-Bed Specialist Hospital which is designed to complement the pharmaceutical manufacturing facility. NBT will provide a site for performing Phase I-IV clinical trials in a wide variety of diseases.

WE OFFER FULL-SERVICE, END-TO-END CUSTOMIZED SOLUTIONS AND STRATEGIES, WHICH COVERS EVERY ASPECT OF CLINICAL TESTING

Our experienced team takes pride in its ability to consult and plan for every step of developing and testing medical therapies.

NBT has an extensive network of investigators, clinicians and patients. We tap our regulatory expertise, data and business analytics, and proven laboratory services to work effectively with pharmaceutical, biotech, medical device, academic, government and public health organizations in clinical testing.

We understand that each customer has unique needs and work to design innovative, custom solutions across the full drug development life cycle.

For more information, please send inquiries to: info@nampeva.com

About NBT

NampEVA BioTherapeutics (NBT) LLC, is a Dover, DE incorporated privately owned biopharmaceutical company dedicated to delivering affordable cancer specialty medicines to approximately 2 billion people in 85 countries classified as Low to Middle Income Countries (LMIC) by the World Bank, and with a corporate social responsibility (CSR) to reinvest locally to promote medical, science and technology education.

Products

Designed & Developed by PERFECT Web Solutions™